A recent study looked at 679 patients across 21 global sites in the U.S., Canada, and Hong Kong, Johnson & Johnson MedTech said.
Johnson & Johnson completes first cases with OTTAVA robotic surgical system
Upon completion of the study, J&J plans to submit the OTTAVA system for De Novo authorization in the U.S.
Johnson & Johnson MedTech launches Dualto generator that will work with Ottava surgical robot
Johnson & Johnson designed Dualto to deliver the choice of powering monopolar, bipolar, ultrasonic, or advanced bipolar instruments.